Background Heart failure with preserved ejection fraction (HFpEF) is characterised by systemic congestion and elevated left ...

Q: Can you tell me about ejection fractions? My wife’s heart doctor recently told us that her heart is weak, and she has a low ejection fraction. He did not discuss this much, but he has put her on ...

Early report on modular BioVAT patches in advanced stage C or D disease ...

LONDON — The benefit of mineralocorticoid receptor antagonists (MRAs) for the treatment of patients with heart failure and mildly reduced or preserved ejection fraction has finally been established in ...

In a population of patients with HF and low ejection, those aged at least 63 years had significantly reduced verbal memory compared with younger patients, new study results indicated. The ...

BARCELONA, Spain—Two in five patients with heart failure (HF) have high inflammatory risk, with a similar prevalence across ...

The role of ACE inhibitors in the management of HFPEF is less significant compared with their role in the management of heart failure with left ventricular systolic dysfunction. For patients with ...

Reclassifying HFmrEF as a stable phenotype aims to reduce therapeutic inertia and GDMT underuse driven by heterogeneous ...

Among patients with heart failure with preserved ejection fraction (HFpEF), lower versus higher ranges of EF signal fundamentally different morphologies and hemodynamic responses, which may have ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF software. This software utilises AI to detect individuals with a low left ...